Chrétien P, Dauvin M, Hélin P, Ocwieja T, Absalon Y B, Johanet C
Laboratoire d'immunologie, centre hospitalier intercommunal, Créteil, France.
Ann Biol Clin (Paris). 1994;52(9):645-50.
Anti-native DNA (ds DNA) antibodies were measured by the Farr assay, an indirect immunofluorescence on Crithidia luciliae (IIFCL) and a newly commercialised enzyme-linked immunosorbent assay (Elisa) in the sera of 270 patients: 73 negative controls, 67 patients with systemic lupus erythematosus (SLE), 73 with clinical symptoms of another connective tissue disease and 61 patients with liver diseases. The Farr assay remains a reliable method, IIFCL seems to be as specific but less sensitive and Elisa has a higher sensitivity but a lower specificity. Finally, 35 sera from the 270 patients were tested for anti-ds DNA antibodies using two other commercialised Elisa-related techniques. The results suggest little correlation between the three Elisa methods.
采用Farr试验、利什曼原虫间接免疫荧光法(IIFCL)以及一种新商业化的酶联免疫吸附测定法(ELISA),对270例患者血清中的抗天然DNA(双链DNA)抗体进行检测,这些患者包括73例阴性对照、67例系统性红斑狼疮(SLE)患者、73例有其他结缔组织病临床症状的患者以及61例肝病患者。Farr试验仍然是一种可靠的方法,IIFCL似乎同样具有特异性,但敏感性较低,而ELISA具有较高的敏感性,但特异性较低。最后,使用另外两种商业化的与ELISA相关的技术,对这270例患者中的35份血清进行了抗双链DNA抗体检测。结果表明这三种ELISA方法之间相关性很小。